Anhui Province Cancer Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03520439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Anhui Province Cancer Hospital | Fang Deng | The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Active Ingredients

Drugs in Phase 3 Trials (1)

mifepristone (mifeprex) (1 trial)

Drugs in Phase 2 Trials (1)

bacille calmette-guerin (1 trial)

Drugs in Phase 1 Trials (6)

cyclophosphamide (cytoxan) (1 trial)

fludarabine (fludara) (1 trial)

Ga 68 PSMA-11 (Illuccix) (1 trial)

thiscart22 cells (1 trial)

thiscart7 cells (1 trial)

utaa09 (1 trial)

Drugs in Other Trials (1)

Bacterial Lysates (pulmonarom) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenomyosis (Phase 3)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 9